Women First HealthCare acquires Vaniqa, plans relaunch


San Diego - With its acquisition from Bristol-Myers Squibb of worldwide rights and title to Vaniqa (eflornithine hydrochloride) Cream, Women First HealthCare plans to take another pass at providing women with hirsutism a pharmaceutical alternative.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.